Baran Y - Search Results

1

The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.

Cakir Z, Saydam G, Sahin F, Baran Y. Cakir Z, et al. Among authors: baran y. J Cancer Res Clin Oncol. 2011 Feb;137(2):279-86. doi: 10.1007/s00432-010-0884-x. Epub 2010 Apr 18. J Cancer Res Clin Oncol. 2011. PMID: 20401667

2

Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine.

Baran Y, Gunduz U, Ural AU. Baran Y, et al. Exp Oncol. 2006 Jun;28(2):163-5. Exp Oncol. 2006. PMID: 16837911

3

Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells.

Gucluler G, Baran Y. Gucluler G, et al. Among authors: baran y. Hematology. 2009 Jun;14(3):139-44. doi: 10.1179/102453309X426164. Hematology. 2009. PMID: 19490758 Free article.

4

Nilotinib significantly induces apoptosis in imatinib-resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts.

Ekiz HA, Can G, Gunduz U, Baran Y. Ekiz HA, et al. Among authors: baran y. Hematology. 2010 Feb;15(1):33-8. doi: 10.1179/102453310X12583347009775. Hematology. 2010. PMID: 20132660 Free article.

5

Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells.

Avcı CB, Gündüz C, Baran Y, Sahin F, Yılmaz S, Dogan ZO, Saydam G. Avcı CB, et al. Among authors: baran y. J Cancer Res Clin Oncol. 2011 Jan;137(1):41-7. doi: 10.1007/s00432-010-0857-0. Epub 2010 Mar 10. J Cancer Res Clin Oncol. 2011. PMID: 20221636

6

Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells.

Baran Y, Oztekin C, Bassoy EY. Baran Y, et al. Cancer Invest. 2010 Jul;28(6):623-8. doi: 10.3109/07357901003631056. Cancer Invest. 2010. PMID: 20307198 Free article.

7

Therapeutic applications of bioactive sphingolipids in hematological malignancies.

Ekiz HA, Baran Y. Ekiz HA, et al. Among authors: baran y. Int J Cancer. 2010 Oct 1;127(7):1497-506. doi: 10.1002/ijc.25478. Int J Cancer. 2010. PMID: 20503271 Free article. Review.

8

Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells.

Kosova B, Tezcanli B, Ekiz HA, Cakir Z, Selvi N, Dalmizrak A, Kartal M, Gunduz U, Baran Y. Kosova B, et al. Among authors: baran y. Leuk Lymphoma. 2010 Oct;51(10):1895-901. doi: 10.3109/10428194.2010.507830. Leuk Lymphoma. 2010. PMID: 20849385

9

Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition.

Baran Y, Zencir S, Cakir Z, Ozturk E, Topcu Z. Baran Y, et al. J Clin Pharm Ther. 2011 Dec;36(6):673-9. doi: 10.1111/j.1365-2710.2010.01224.x. Epub 2010 Nov 24. J Clin Pharm Ther. 2011. PMID: 21105880

10

Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells.

Can G, Ekiz HA, Baran Y. Can G, et al. Among authors: baran y. Hematology. 2011 Mar;16(2):95-9. doi: 10.1179/102453311X12902908412039. Hematology. 2011. PMID: 21418740 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters